Editing Openai/69668f73-ea68-800d-ac56-44a64b19dae4 (section)

==== Not in a sentimental way — but yes, in a structural / fairness way. ====

The Court (especially the liberals, and also Roberts/Barrett) is sensitive to:
* Asymmetric power
* Asymmetric access to proof
* Situations where formal rules systematically favor the powerful over the vulnerable
* Situations where procedural doctrines become shields for strategic wrongdoing

A “tiny innovator vs large generic” frame maps onto that concern much more naturally than “Big Pharma vs scrappy generic.”

So this nudges the liberals toward sympathy for Amarin’s position, if the story is presented that way.

But: sympathy does not equal cert votes.